Methyl 1-benzyl-3-[[4-[(5-methyl-2-phenyl-1,3-oxazol-4-yl)methoxy]phenyl]sulfonylamino]pyrazole-4-carboxylate
C29H26N4O6S — CID 11341956
Data last refreshed: (MolForge compound catalog, from PubChem)
About Methyl 1-benzyl-3-[[4-[(5-methyl-2-phenyl-1,3-oxazol-4-yl)methoxy]phenyl]sulfonylamino]pyrazole-4-carboxylate
Methyl 1-benzyl-3-[[4-[(5-methyl-2-phenyl-1,3-oxazol-4-yl)methoxy]phenyl]sulfonylamino]pyrazole-4-carboxylate (PubChem CID 11341956) has the molecular formula C29H26N4O6S and a molecular weight of 558.62 g/mol. Its IUPAC name is methyl 1-benzyl-3-[[4-[(5-methyl-2-phenyl-1,3-oxazol-4-yl)methoxy]phenyl]sulfonylamino]pyrazole-4-carboxylate.
Molecular Properties
| Compound Name | Methyl 1-benzyl-3-[[4-[(5-methyl-2-phenyl-1,3-oxazol-4-yl)methoxy]phenyl]sulfonylamino]pyrazole-4-carboxylate |
|---|---|
| PubChem CID | 11341956 |
| Molecular Formula | C29H26N4O6S |
| Molecular Weight | 558.62 g/mol |
| Exact Mass | 558.16 |
| IUPAC Name | methyl 1-benzyl-3-[[4-[(5-methyl-2-phenyl-1,3-oxazol-4-yl)methoxy]phenyl]sulfonylamino]pyrazole-4-carboxylate |
| SMILES | COC(=O)c1cn(Cc2ccccc2)nc1NS(=O)(=O)c1ccc(OCc2nc(-c3ccccc3)oc2C)cc1 |
| InChI | InChI=1S/C29H26N4O6S/c1-20-26(30-28(39-20)22-11-7-4-8-12-22)19-38-23-13-15-24(16-14-23)40(35,36)32-27-25(29(34)37-2)18-33(31-27)17-21-9-5-3-6-10-21/h3-16,18H,17,19H2,1-2H3,(H,31,32) |
| InChIKey | OCXDGNUWBGGSOW-UHFFFAOYSA-N |
| XLogP | 5.06 |
| TPSA | 125.55 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 40 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 558.62 |
| LogP ≤ 5 | 5.06 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 9 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 11341956 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.